ACS Nano,
Год журнала:
2022,
Номер
16(9), С. 13513 - 13553
Опубликована: Сен. 1, 2022
Prodrugs
are
chemically
modified
drug
molecules
that
inactive
before
administration.
After
administration,
they
converted
in
situ
to
parent
drugs
and
induce
the
mechanism
of
action.
The
development
prodrugs
has
upgraded
conventional
treatments
terms
bioavailability,
targeting,
reduced
side
effects.
Especially
cancer
therapy,
application
achieved
substantial
therapeutic
From
serendipitous
discovery
early
stage
functional
design
with
pertinence
nowadays,
importance
is
self-evident.
At
present,
studying
stimuli-responsive
activation
mechanisms,
regulating
stimuli
intensity
vivo,
designing
nanoscale
prodrug
formulations
major
strategies
promote
prodrugs.
In
this
review,
we
provide
an
outlook
recent
cutting-edge
studies
on
nanosystems
from
these
three
aspects.
We
also
discuss
prospects
challenges
future
such
Angewandte Chemie International Edition,
Год журнала:
2019,
Номер
58(24), С. 8161 - 8165
Опубликована: Апрель 17, 2019
Despite
its
great
potential
in
cancer
treatment,
photodynamic
therapy
(PDT)
often
exacerbates
hypoxia
and
subsequently
compromises
therapeutic
efficacy.
To
overcome
this
issue,
an
organic
nanoinhibitor
(OPNi)
has
been
synthesized
that
the
additional
ability
to
counteract
carbonic
anhydrase
IX
(CA-IX),
a
molecular
target
hypoxia-mediated
signalling
cascade.
OPNi
is
composed
of
metabolizable
semiconducting
polymer
as
photosensitizer
CA-IX
antagonist
conjugated
amphiphilic
matrix.
This
structure
allows
not
only
selectively
bind
positive
cells
facilitate
tumor
accumulation
but
also
regulate
CA-IX-related
pathway.
The
integration
inhibition
into
targeted
PDT
process
eventually
synergistic
effect,
leading
superior
antitumor
efficacy
over
alone,
well
reduced
probability
hypoxia-induced
metastasis.
study
thus
proposes
strategy
devise
simple
yet
amplified
photosensitizers
conquer
pitfalls
traditional
PDT.
Angewandte Chemie International Edition,
Год журнала:
2020,
Номер
59(18), С. 7069 - 7075
Опубликована: Фев. 4, 2020
Abstract
Pt
II
complexes
are
commonly
used
to
treat
cancer.
To
reduce
their
side
effects
and
improve
pharmacological
properties,
IV
being
developed
as
prodrug
candidates
that
activated
by
reduction
in
cancer
cells.
Concomitantly,
Ru
polypyridine
have
gained
much
attention
photosensitizers
for
use
photodynamic
therapy
due
attractive
characteristics.
In
this
article,
a
novel
–Ru
conjugate,
which
combines
chemotherapy
with
PDT,
is
presented.
Upon
entering
the
cell,
centre
reduced
axial
ligands
including
complex
phenylbutyrate
released.
As
each
component
has
its
individual
targets,
conjugate
exerts
multi‐target
multi‐action
effect
(photo‐)cytotoxicity
values
upon
irradiation
up
595
nm
low
nanomolar
range
various
(drug
resistant)
2D
monolayer
cells
3D
multicellular
tumour
spheroids.
Abstract
The
combination
of
chemotherapy
and
photodynamic
therapy
(PDT)
has
promising
potential
in
the
synergistic
treatment
cancer.
However,
are
impeded
by
uncontrolled
chemotherapeutics
release
behavior,
targeting
deficiencies,
hypoxia‐associated
poor
PDT
efficacy
solid
tumors.
Here,
a
platinum
nanozyme
(PtNP)
loaded
reactive
oxygen
species
(ROS)‐responsive
prodrug
nanoparticle
(CPT‐TK‐HPPH/Pt
NP)
is
created
to
overcome
these
limitations.
ROS‐responsive
consists
thioketal
bond
linked
with
camptothecin
(CPT)
photosensitizer‐2‐(1‐hexyloxyethyl)‐2‐devinyl
pyropheophorbide‐a
(HPPH).
PtNP
CPT‐TK‐HPPH/Pt
NP
can
efficiently
catalyze
decomposition
hydrogen
peroxide
(H
2
O
)
into
relieve
hypoxia.
production
satisfy
consumption
HPPH
under
660
nm
laser
irradiation
attain
on‐demand
CPT
ensure
enhanced
therapy.
As
tumor
diagnosis
agent,
results
photoacoustic
imaging
fluorescence
for
exhibit
desirable
long
circulation
vivo
targeting.
NPs
effectively
inhibit
proliferation
growth
vitro
vivo.
NP,
its
excellent
drug
behavior
efficiency
serve
as
new
cancer
theranostic
will
further
promote
research
chemophotodynamic
Journal of the American Chemical Society,
Год журнала:
2022,
Номер
144(5), С. 2360 - 2367
Опубликована: Янв. 20, 2022
Considering
that
hypoxia
is
closely
associated
with
tumor
proliferation,
invasion,
metastasis,
and
drug
resistance,
it
of
great
significance
to
overcome
in
treatment.
Herein,
we
report
a
hypoxia-induced
specific
photothermal
therapy
(PTT)
based
on
the
agent
supramolecular
perylene
diimide
radical
anions.
Hypoxic
regions
various
tumors
display
strong
reductive
ability,
such
environments
complex
derivative
cucurbit[7]uril
could
be
reduced
Benefiting
from
NIR
absorption
good
conversion
performance
situ
generated
anions,
PTT
strategy
exhibits
excellent
therapeutic
efficiency
as
well
specificity
biological
safety.
Moreover,
inducible
factor
expression
decreases
normal
level
after
It
anticipated
opens
new
horizons
for
against
hypoxic
improved
Journal of the American Chemical Society,
Год журнала:
2021,
Номер
143(34), С. 13980 - 13989
Опубликована: Авг. 24, 2021
Most
photodynamic
therapy
(PDT)
paradigms
work
through
the
highly
O2-dependent
type
II
photoreaction
to
generate
singlet
oxygen
(1O2).
The
hypoxic
microenvironment
of
solid
tumors
severely
hampers
therapeutic
outcomes.
Here,
we
present
a
novel
design
that
could
transfer
photophysical
and
photochemical
properties
traditional
phthalocyanine-based
photosensitizers
from
efficient
I
vibrational
relaxation-induced
photothermal
conversion.
These
features
enable
obtained
nanostructured
phthalocyanine
assemblies
(e.g.,
NanoPcAF)
display
excellent
phototherapies
under
both
normoxic
conditions.
Moreover,
NanoPcAF
has
high
level
accumulation
in
tumor
tissues
after
intravenous
injection,
94%
growth
is
inhibited
preclinical
model
at
dose
0.8
nmol
g–1
light
300
J
cm–2.
Journal of the American Chemical Society,
Год журнала:
2022,
Номер
144(9), С. 4091 - 4101
Опубликована: Фев. 16, 2022
Despite
the
clinical
success
of
photodynamic
therapy
(PDT),
application
this
medical
technique
is
intrinsically
limited
by
low
oxygen
concentrations
found
in
cancer
tumors,
hampering
production
therapeutically
necessary
singlet
(1O2).
To
overcome
limitation,
we
report
on
a
novel
mitochondria-localized
iridium(III)
endoperoxide
prodrug
(2-O-IrAn),
which,
upon
two-photon
irradiation
NIR,
synergistically
releases
highly
cytotoxic
complex
(2-IrAn),
oxygen,
and
an
alkoxy
radical.
2-O-IrAn
was
to
be
(photo-)toxic
hypoxic
tumor
cells
multicellular
spheroids
(MCTS)
nanomolar
range.
provide
selectivity
improve
pharmacological
properties
2-O-IrAn,
it
encapsulated
into
biotin-functionalized
polymer.
The
generated
nanoparticles
were
nearly
fully
eradicate
inside
mouse
model
within
single
treatment.
This
study
presents,
best
our
knowledge,
first
example
iridium(III)-based
for
synergistic
therapy/photoactivated
chemotherapy,
opening
up
new
avenues
treatment
tumors.
ACS Nano,
Год журнала:
2021,
Номер
15(2), С. 2068 - 2098
Опубликована: Фев. 8, 2021
Materials
that
respond
to
endogenous
stimuli
are
being
leveraged
enhance
spatiotemporal
control
in
a
range
of
biomedical
applications
from
drug
delivery
diagnostic
tools.
The
design
materials
undergo
morphological
or
chemical
changes
response
specific
biological
cues
pathologies
will
be
an
important
area
research
for
improving
efficacies
existing
therapies
and
imaging
agents,
while
also
promising
developing
personalized
theranostic
systems.
Internal
stimuli-responsive
systems
can
engineered
across
length
scales
nanometers
macroscopic
signals
such
as
enzymes,
pH,
glucose,
ATP,
hypoxia,
redox
signals,
nucleic
acids
by
incorporating
synthetic
bio-inspired
moieties
natural
building
blocks.
This
Review
summarize
mechanisms
fabrication
strategies
used
internal
with
focus
on
broad
pathologies,
including
cancer,
diabetes,
vascular
disorders,
inflammation,
microbial
infections.
We
discuss
observed
challenges,
future
directions,
clinical
translation
aspects
these
responsive
materials.
Chemical Reviews,
Год журнала:
2024,
Номер
124(5), С. 2699 - 2804
Опубликована: Фев. 29, 2024
The
ability
to
gain
spatiotemporal
information,
and
in
some
cases
achieve
control,
the
context
of
drug
delivery
makes
theranostic
fluorescent
probes
an
attractive
intensely
investigated
research
topic.
This
interest
is
reflected
steep
rise
publications
on
topic
that
have
appeared
over
past
decade.
Theranostic
probes,
their
various
incarnations,
generally
comprise
a
fluorophore
linked
masked
drug,
which
released
as
result
certain
stimuli,
with
both
intrinsic
extrinsic
stimuli
being
reported.
release
then
signaled
by
emergence
signal.
Importantly,
use
appropriate
fluorophores
has
enabled
not
only
this
emerging
fluorescence
marker
for
but
also
provided
modalities
useful
photodynamic,
photothermal,
sonodynamic
therapeutic
applications.
In
review
we
highlight
recent
work
particular
focus
are
activated
tumor
microenvironments.
We
summarize
efforts
develop
other
applications,
such
neurodegenerative
diseases
antibacterials.
celebrates
diversity
designs
reported
date,
from
discrete
small-molecule
systems
nanomaterials.
Our
aim
provide
insights
into
potential
clinical
impact
still-emerging
direction.
Angewandte Chemie International Edition,
Год журнала:
2022,
Номер
61(28)
Опубликована: Май 9, 2022
Abstract
The
clinical
application
of
photodynamic
therapy
is
hindered
by
the
high
glutathione
concentration,
poor
cancer‐targeting
properties,
drug
loading
into
delivery
systems,
and
an
inefficient
activation
cell
death
machinery
in
cancer
cells.
To
overcome
these
limitations,
herein,
formulation
a
promising
Ir
III
complex
biodegradable
coordination
polymer
(
IrS
NPs
)
presented.
nanoparticles
were
found
to
remain
stable
under
physiological
conditions
but
deplete
disintegrate
monomeric
metal
complexes
tumor
microenvironment,
causing
enhanced
therapeutic
effect.
selectively
accumulate
mitochondria
where
trigger
hybrid
apoptosis
ferroptosis
pathways
through
photoinduced
production
singlet
oxygen
superoxide
anion
radicals.
This
study
presents
first
example
that
can
efficiently
cause
upon
irradiation,
providing
innovative
approach
for
therapy.
ACS Nano,
Год журнала:
2023,
Номер
17(10), С. 9110 - 9125
Опубликована: Май 5, 2023
Hypoxia,
the
hallmark
of
malignant
tumors,
has
been
recognized
as
a
major
obstacle
for
photodynamic
therapy
(PDT).
Precisely
targeting
cancer
cells
in
intricate
biological
scenarios
by
hypoxia-resistant
photosensitizer
(PS)
is
cornerstone
to
conquer
inevitable
tumor
recurrence
and
metastasis.
Herein,
we
describe
an
organic
NIR-II
PS
(TPEQM-DMA)
possessing
potent
type-I
phototherapeutic
efficacy
overcome
intrinsic
pitfalls
PDT
combating
hypoxic
tumors.
TPEQM-DMA
exhibited
prominent
emission
(>1000
nm)
with
aggregation-induced
feature
efficiently
produced
superoxide
anion
hydroxyl
radical
aggregate
state
under
white
light
irradiation
exclusively
through
low-O2-dependent
photochemical
process.
The
suitable
cationic
nature
assisted
accumulate
cancerous
mitochondria.
Meanwhile,
impaired
cellular
redox
homeostasis,
led
mitochondrial
dysfunction,
raised
level
lethal
peroxidized
lipids,
which
induced
apoptosis
ferroptosis.
This
synergistic
cell
death
modality
enabled
suppress
growth
cells,
multicellular
spheroids,
To
improve
pharmacological
properties
TPEQM-DMA,
nanoparticles
were
prepared
encapsulation
polymer.
In
vivo
experiments
proved
appealing
fluorescence
imaging-guided
effect